Inconsistent Increase in Age at Respiratory Syncytial Virus Hospitalization of Children Aged 2 Years During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Retrospective Multicenter Study in 4 European Countries
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic disrupted respiratory syncytial virus (RSV) seasonality.
Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice
Up to 25% of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit postacute cognitive sequelae.
First encounter with SARS-CoV-2: immune portraits of COVID susceptibility
More than four years after the start of the COVID-19 pandemic, and the mass mobilization of the scientific community.
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
News
Policy & Recommendations
WHO Europe launches the first Pan-European Network for Disease Control
Hosted by UKHSA and initially chaired by Dame Jenny Harries, the new Network will strengthen disease surveillance and outbreak response across the European Region
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
It is well-established that older adults are at increased risk of severe and fatal COVID-19, but the mechanisms underlying this susceptibility are not entirely clear.
News
Scientific Papers
Article
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
tudy using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults
News
Policy & Recommendations
Health emergency response governance in the EU after the COVID-19 pandemic
More than four years on since the start of the Covid-19 pandemic, this paper provides an assessment of reforms implemented at EU level to enhance the EU’s preparedness and response to future health threats.
Time for Top Leaders to Join Pandemic Negotiations
Two final – and likely sleepless – weeks of negotiation on the pandemic agreement began on Monday 18 March, and negotiators have been urged to bring in their principals to ensure speed up decision-making.
COVID-19 Shows Why the World Needs a Pandemic Agreement
Dr. Tedros Adhanom Ghebreyesus on how we must prepare now to counter the threat of a future pandemic.
Overcoming the COVID-19 pandemic together and building a Health Union
In 2020, the world was hit by the worst pandemic of our generation. At the heart of the European Commission’s response to COVID-19 were cooperation and solidarity.